DD148050A5 - Verfahren zur herstellung neuer n-aryl-bzw.benzimidazolione - Google Patents
Verfahren zur herstellung neuer n-aryl-bzw.benzimidazolione Download PDFInfo
- Publication number
- DD148050A5 DD148050A5 DD77217954A DD21795477A DD148050A5 DD 148050 A5 DD148050 A5 DD 148050A5 DD 77217954 A DD77217954 A DD 77217954A DD 21795477 A DD21795477 A DD 21795477A DD 148050 A5 DD148050 A5 DD 148050A5
- Authority
- DD
- German Democratic Republic
- Prior art keywords
- alkylene
- group
- preparation
- general formula
- application
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/22—Oxygen atoms attached in position 2 or 4
- C07D215/227—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C07D209/32—Oxygen atoms
- C07D209/34—Oxygen atoms in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/30—Oxygen or sulfur atoms
- C07D233/32—One oxygen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
- C07D235/26—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
- C07D265/04—1,3-Oxazines; Hydrogenated 1,3-oxazines
- C07D265/12—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems
- C07D265/14—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D265/18—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with hetero atoms directly attached in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
- C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pain & Pain Management (AREA)
- Cardiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Quinoline Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19762644833 DE2644833A1 (de) | 1976-10-05 | 1976-10-05 | Neue 1-aryloxy-2-hydroxy-3-alkylenaminopropane und verfahren zu ihrer herstellung |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DD148050A5 true DD148050A5 (de) | 1981-05-06 |
Family
ID=5989679
Family Applications (5)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DD77217954A DD148050A5 (de) | 1976-10-05 | 1977-10-03 | Verfahren zur herstellung neuer n-aryl-bzw.benzimidazolione |
| DD77201314A DD134642A5 (de) | 1976-10-05 | 1977-10-03 | Verfahren zur herstellung neuer 1-aryloxy-2-hydroxy-3-alkylenaminopropane |
| DD77212491A DD143074A5 (de) | 1976-10-05 | 1977-10-03 | Verfahren zur herstellung neuer n-aryl bzw.benzimidazolinone |
| DD77217956A DD148051A5 (de) | 1976-10-05 | 1977-10-03 | Verfahren zur herstellung neuer zwischenprodukte zur herstellung pharmazeutisch verwendbarer verbindungen |
| DD77217961A DD148052A5 (de) | 1976-10-05 | 1977-10-03 | Verfahren zur herstellung neuer zwischenprodukte von arzneimitteln |
Family Applications After (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DD77201314A DD134642A5 (de) | 1976-10-05 | 1977-10-03 | Verfahren zur herstellung neuer 1-aryloxy-2-hydroxy-3-alkylenaminopropane |
| DD77212491A DD143074A5 (de) | 1976-10-05 | 1977-10-03 | Verfahren zur herstellung neuer n-aryl bzw.benzimidazolinone |
| DD77217956A DD148051A5 (de) | 1976-10-05 | 1977-10-03 | Verfahren zur herstellung neuer zwischenprodukte zur herstellung pharmazeutisch verwendbarer verbindungen |
| DD77217961A DD148052A5 (de) | 1976-10-05 | 1977-10-03 | Verfahren zur herstellung neuer zwischenprodukte von arzneimitteln |
Country Status (33)
| Country | Link |
|---|---|
| US (7) | US4212877A (cs) |
| JP (1) | JPS5368775A (cs) |
| AT (15) | AT361908B (cs) |
| AU (1) | AU514600B2 (cs) |
| BE (1) | BE859415A (cs) |
| BG (1) | BG33153A3 (cs) |
| CA (4) | CA1101859A (cs) |
| CS (1) | CS197304B2 (cs) |
| DD (5) | DD148050A5 (cs) |
| DE (1) | DE2644833A1 (cs) |
| DK (1) | DK439077A (cs) |
| ES (16) | ES462868A1 (cs) |
| FI (1) | FI69066C (cs) |
| FR (1) | FR2394534A1 (cs) |
| GB (3) | GB1592975A (cs) |
| GR (1) | GR64229B (cs) |
| HK (1) | HK19385A (cs) |
| HU (1) | HU177173B (cs) |
| IE (3) | IE46158B1 (cs) |
| IL (1) | IL53043A (cs) |
| LU (1) | LU78240A1 (cs) |
| MY (1) | MY8500909A (cs) |
| NL (1) | NL7710840A (cs) |
| NO (1) | NO151411C (cs) |
| NZ (1) | NZ185356A (cs) |
| PH (4) | PH15763A (cs) |
| PL (1) | PL113879B1 (cs) |
| PT (1) | PT67107B (cs) |
| SE (1) | SE442400B (cs) |
| SG (1) | SG70884G (cs) |
| SU (1) | SU665801A3 (cs) |
| YU (1) | YU40484B (cs) |
| ZA (1) | ZA775905B (cs) |
Families Citing this family (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4404380A (en) * | 1977-02-14 | 1983-09-13 | Mead Johnson & Company | Triazolopyrimidines |
| DE2833140A1 (de) * | 1978-07-28 | 1980-02-07 | Boehringer Sohn Ingelheim | Neue n-substituierte heterocyclen |
| SE8003277L (sv) * | 1979-05-04 | 1980-11-05 | Continental Pharma | Bensimidazolderivat, deras framstellning och anvendning samt kompositioner innehallande dessa derivat |
| US4434174A (en) | 1980-02-11 | 1984-02-28 | Berlex Laboratories, Inc. | Treating cardiovascular diseases with N-(3-phenoxy-2-hydroxypropyl)benzimidazole-1-alkanamines |
| EP0034116A3 (en) | 1980-02-11 | 1981-09-02 | Berlex Laboratories, Inc. | N-(3-phenoxy-2-hydroxypropyl)benzimidazole-1-alkanamines |
| US4656168A (en) * | 1980-12-23 | 1987-04-07 | Merck & Co., Inc. | (3-aralkylamino-2-or-propoxy)heterocyclic compounds in method of effecting bronchodilation |
| US4349673A (en) * | 1980-12-23 | 1982-09-14 | Merck & Co., Inc. | Benzoxazines |
| US4473501A (en) * | 1981-05-04 | 1984-09-25 | G. D. Searle & Co. | Dihydro azino isoquinolines |
| US4379508A (en) * | 1981-10-14 | 1983-04-12 | Nestier Corporation | Nesting tray with stacking keyed interlock |
| IT1193608B (it) * | 1983-01-21 | 1988-07-21 | Pierrel Spa | Derivati di arilossipropanolamina,procedimento per la loro preparazione composizioni farmaceutiche che li contengono e loro impiego terapeutico |
| DE3324903A1 (de) * | 1983-07-09 | 1985-01-17 | Bayer Ag, 5090 Leverkusen | Verfahren zur herstellung substituierter ethylenharnstoffe sowie neue n-vinylethylenharnstoffe |
| GB8419797D0 (en) * | 1984-08-03 | 1984-09-05 | Beecham Group Plc | Compounds |
| DE3807922A1 (de) * | 1988-03-10 | 1989-09-21 | Boehringer Mannheim Gmbh | Substituierte heterocyclen, verfahren zu ihrer herstellung sowie arzneimittel, die diese verbindungen enthalten |
| TW203049B (cs) * | 1990-04-13 | 1993-04-01 | Yamanouchi Pharma Co Ltd | |
| US6557907B2 (en) | 1993-05-14 | 2003-05-06 | William W. Rowley | Polyethylene connectors |
| US6860524B1 (en) | 1993-05-14 | 2005-03-01 | William W. Rowley | Polyolefin connectors |
| DE69942578D1 (de) | 1998-05-22 | 2010-08-26 | Univ R | Bifunktionelle moleküle sowie darauf basierende therapien. |
| CA2450073C (en) | 2001-07-25 | 2017-08-29 | Biomarin Pharmaceutical Inc. | Compositions and methods for modulating blood-brain barrier transport |
| US6848719B2 (en) | 2001-09-06 | 2005-02-01 | William W. Rowley | Bendable polymer-lined water heater connector |
| TWI316511B (en) * | 2002-11-26 | 2009-11-01 | Smithkline Beecham Corp | Calcilytic compounds |
| WO2004058726A2 (en) * | 2002-12-23 | 2004-07-15 | Artesian Therapeutics, Inc. | CARDIOTONIC COMPOUNDS WITH INHIBITORY ACTIVITY AGAINST β-ADRENERGIC RECEPTORS AND PHOSPHODIESTERASE |
| DE102004045648A1 (de) * | 2004-09-21 | 2006-03-23 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Neue Betamimetika zur Behandlung von Atemwegserkrankungen |
| WO2006060122A2 (en) * | 2004-11-30 | 2006-06-08 | Artesian Therapeutics, Inc. | Cardiotonic compounds with inhibitory activity against beta-adrenergic receptors and phosphodiesterase |
| JP2008539047A (ja) | 2005-04-28 | 2008-11-13 | プロテウス バイオメディカル インコーポレイテッド | ファーマインフォーマティックスシステム |
| CN101594878A (zh) | 2006-09-18 | 2009-12-02 | 雷普特药品公司 | 通过给予受体相关蛋白（rap）-缀合物对肝病症的治疗 |
| PL3075401T3 (pl) * | 2007-11-29 | 2024-08-19 | Inolex Investment Corporation | Środek konserwujący dla kompozycji kosmetycznych, toaletowych i farmaceutycznych |
| EP3395372B1 (en) | 2009-02-20 | 2022-04-06 | EnhanX Biopharm Inc. | Glutathione-based drug delivery system |
| SG10201402069PA (en) | 2009-05-06 | 2014-07-30 | Lab Skin Care Inc | Dermal delivery compositions comprising active agent-calcium phosphate particle complexes and methods of using the same |
| US20120077778A1 (en) | 2010-09-29 | 2012-03-29 | Andrea Bourdelais | Ladder-Frame Polyether Conjugates |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL284529A (cs) * | 1961-10-24 | |||
| GB1066613A (en) * | 1965-03-03 | 1967-04-26 | Ici Ltd | Naphthalene derivatives |
| DE2065365C3 (de) * | 1969-11-28 | 1982-05-06 | Teikoku Hormone Mfg. Co. Ltd., Tokyo | 1,3-disubstituierte Azetidine sowie Verfahren zu deren Herstellung und ihre Anwendung |
| ZA71932B (en) * | 1970-02-27 | 1971-10-27 | Ici Ltd | Organic compounds |
| BE787103A (fr) * | 1971-08-04 | 1973-02-02 | Pfizer | Nouveaux derives de propanolamine et composition pharmaceutiqueles contenant |
| US3818017A (en) * | 1973-01-04 | 1974-06-18 | Janssen Pharmaceutica Nv | 1-{8 1-(2-hydroxy-3-aryloxypropyl)-4-piperidyl{9 -2-benzimidazolinones and related compounds |
| US3894030A (en) * | 1973-01-04 | 1975-07-08 | Janssen Pharmaceutica Nv | 1-{8 1-(2-Hydroxy-3-aryloxypropyl)-4-piperidyl{9 -2-benzimidazolinones and related compounds |
| GB1456525A (en) * | 1973-07-18 | 1976-11-24 | Ici Ltd | Process for the manufacture of alkanolamine derivatives |
| DE2503222A1 (de) * | 1975-01-27 | 1976-07-29 | Boehringer Sohn Ingelheim | Verfahren zur herstellung von 1-aryl- oxy-3-n-substituierten aminopropanderivaten |
| US4081447A (en) * | 1975-04-09 | 1978-03-28 | Abbott Laboratories | 5-[2-Hydroxy-3-(3,4-dimethoxy phenethylamino)]-propoxy-3,4-dihydro carbostyril and pharmaceutically acceptable salts thereof |
| CH624395A5 (cs) * | 1976-01-08 | 1981-07-31 | Ciba Geigy Ag | |
| DE2609645A1 (de) * | 1976-03-09 | 1977-09-15 | Boehringer Sohn Ingelheim | Aminoalkylheterocyclen |
-
1976
- 1976-10-05 DE DE19762644833 patent/DE2644833A1/de not_active Withdrawn
-
1977
- 1977-09-22 AT AT679377A patent/AT361908B/de not_active IP Right Cessation
- 1977-09-26 FI FI772823A patent/FI69066C/fi not_active IP Right Cessation
- 1977-10-03 BG BG037483A patent/BG33153A3/xx unknown
- 1977-10-03 LU LU7778240A patent/LU78240A1/xx unknown
- 1977-10-03 DD DD77217954A patent/DD148050A5/de unknown
- 1977-10-03 DD DD77201314A patent/DD134642A5/xx unknown
- 1977-10-03 IL IL53043A patent/IL53043A/xx unknown
- 1977-10-03 HU HU77BO1685A patent/HU177173B/hu unknown
- 1977-10-03 DD DD77212491A patent/DD143074A5/de unknown
- 1977-10-03 DD DD77217956A patent/DD148051A5/de unknown
- 1977-10-03 PT PT67107A patent/PT67107B/pt unknown
- 1977-10-03 DD DD77217961A patent/DD148052A5/de unknown
- 1977-10-04 ES ES462868A patent/ES462868A1/es not_active Expired
- 1977-10-04 ZA ZA00775905A patent/ZA775905B/xx unknown
- 1977-10-04 GR GR54491A patent/GR64229B/el unknown
- 1977-10-04 SU SU772527654A patent/SU665801A3/ru active
- 1977-10-04 JP JP11938777A patent/JPS5368775A/ja active Granted
- 1977-10-04 AU AU29333/77A patent/AU514600B2/en not_active Expired
- 1977-10-04 DK DK439077A patent/DK439077A/da not_active Application Discontinuation
- 1977-10-04 PL PL1977201286A patent/PL113879B1/pl unknown
- 1977-10-04 GB GB41251/77A patent/GB1592975A/en not_active Expired
- 1977-10-04 YU YU2369/77A patent/YU40484B/xx unknown
- 1977-10-04 NL NL7710840A patent/NL7710840A/xx not_active Application Discontinuation
- 1977-10-04 NO NO773384A patent/NO151411C/no unknown
- 1977-10-04 GB GB41737/79A patent/GB1592976A/en not_active Expired
- 1977-10-04 CA CA288,058A patent/CA1101859A/en not_active Expired
- 1977-10-04 GB GB41738/79A patent/GB1592977A/en not_active Expired
- 1977-10-05 BE BE181490A patent/BE859415A/xx not_active IP Right Cessation
- 1977-10-05 CS CS776449A patent/CS197304B2/cs unknown
- 1977-10-05 SE SE7711168A patent/SE442400B/xx not_active IP Right Cessation
- 1977-10-05 IE IE2038/77A patent/IE46158B1/en unknown
- 1977-10-05 FR FR7729973A patent/FR2394534A1/fr active Granted
- 1977-10-05 NZ NZ185356A patent/NZ185356A/xx unknown
- 1977-10-05 IE IE2409/82A patent/IE46159B1/en unknown
- 1977-10-05 IE IE2410/82A patent/IE46160B1/en unknown
-
1978
- 1978-07-17 ES ES471804A patent/ES471804A1/es not_active Expired
- 1978-07-17 ES ES471806A patent/ES471806A1/es not_active Expired
- 1978-07-17 ES ES471801A patent/ES471801A1/es not_active Expired
- 1978-07-17 ES ES471796A patent/ES471796A1/es not_active Expired
- 1978-07-17 ES ES471802A patent/ES471802A1/es not_active Expired
- 1978-07-17 ES ES471797A patent/ES471797A1/es not_active Expired
- 1978-07-17 ES ES471799A patent/ES471799A1/es not_active Expired
- 1978-07-17 ES ES471794A patent/ES471794A1/es not_active Expired
- 1978-07-17 ES ES471795A patent/ES471795A1/es not_active Expired
- 1978-07-17 ES ES471805A patent/ES471805A1/es not_active Expired
- 1978-07-17 ES ES471807A patent/ES471807A1/es not_active Expired
- 1978-07-17 ES ES471808A patent/ES471808A1/es not_active Expired
- 1978-07-17 ES ES471803A patent/ES471803A1/es not_active Expired
- 1978-07-17 ES ES471800A patent/ES471800A1/es not_active Expired
- 1978-07-17 ES ES471798A patent/ES471798A1/es not_active Expired
-
1979
- 1979-01-17 US US06/004,280 patent/US4212877A/en not_active Expired - Lifetime
- 1979-01-17 US US06/004,279 patent/US4256756A/en not_active Expired - Lifetime
- 1979-08-30 PH PH22979A patent/PH15763A/en unknown
- 1979-12-14 US US06/103,724 patent/US4255430A/en not_active Expired - Lifetime
-
1980
- 1980-01-16 US US06/112,640 patent/US4296117A/en not_active Expired - Lifetime
- 1980-02-04 AT AT56980A patent/AT361913B/de not_active IP Right Cessation
- 1980-02-04 AT AT0057780A patent/AT363081B/de not_active IP Right Cessation
- 1980-02-04 AT AT0057680A patent/AT363080B/de not_active IP Right Cessation
- 1980-02-04 AT AT57880A patent/AT362365B/de not_active IP Right Cessation
- 1980-02-04 AT AT56780A patent/AT361911B/de not_active IP Right Cessation
- 1980-02-04 AT AT56880A patent/AT361912B/de not_active IP Right Cessation
- 1980-02-04 AT AT57180A patent/AT361915B/de not_active IP Right Cessation
- 1980-02-04 AT AT0057980A patent/AT363082B/de not_active IP Right Cessation
- 1980-02-04 AT AT57480A patent/AT362364B/de not_active IP Right Cessation
- 1980-02-04 AT AT57080A patent/AT361914B/de not_active IP Right Cessation
- 1980-02-04 AT AT57380A patent/AT362363B/de not_active IP Right Cessation
- 1980-02-04 AT AT0057580A patent/AT363079B/de not_active IP Right Cessation
- 1980-02-04 AT AT0058080A patent/AT364828B/de not_active IP Right Cessation
- 1980-02-04 AT AT57280A patent/AT362362B/de not_active IP Right Cessation
- 1980-10-09 US US06/195,650 patent/US4381309A/en not_active Expired - Lifetime
- 1980-10-09 PH PH24696A patent/PH16053A/en unknown
-
1981
- 1981-02-05 CA CA370,239A patent/CA1127643A/en not_active Expired
- 1981-02-05 CA CA370,238A patent/CA1125751A/en not_active Expired
- 1981-02-05 CA CA370,237A patent/CA1126271A/en not_active Expired
- 1981-04-20 US US06/255,751 patent/US4343800A/en not_active Expired - Fee Related
-
1982
- 1982-05-10 PH PH27256A patent/PH18363A/en unknown
- 1982-11-11 PH PH28126A patent/PH19028A/en unknown
-
1984
- 1984-07-25 US US06/634,446 patent/US4604468A/en not_active Expired - Fee Related
- 1984-10-05 SG SG708/84A patent/SG70884G/en unknown
-
1985
- 1985-03-14 HK HK193/85A patent/HK19385A/xx unknown
- 1985-12-30 MY MY909/85A patent/MY8500909A/xx unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DD148050A5 (de) | Verfahren zur herstellung neuer n-aryl-bzw.benzimidazolione | |
| DE1236510B (de) | Verfahren zur Herstellung von Acylaminotetramsaeuren | |
| DE2454107A1 (de) | Substituierte harnstoff-, acylharnstoff- und sulfonylharnstoff-derivate und verfahren zu deren herstellung | |
| EP0152598B1 (de) | Cyanomethyl-(2-cyano-ethyl)-(3-hydroxy-propyl)-amin, seine Verwendung zur Herstellung von 1-(3-Hydroxy-propyl)-1,4-diazepan und 1,4 Bis-[3-(3,4,5-trimethoxy-benzoyloxy)-propyl]-diazepan | |
| CH610330A5 (en) | Process for the preparation of novel ergopeptins | |
| DE1695500B2 (de) | Verfahren zum herstellen von 1-methyl- 5-nitroimidazolverbindungen | |
| DE1215729B (de) | Verfahren zur Herstellung von neuen Bis-alkanolaminderivaten und deren Salzen | |
| DE2609574B2 (de) | 1-(4-fluor-3-trifluormethylthio- phenyl)-piperazin, dessen salze, verfahren zu dessen herstellung und arzneimittel | |
| AT215418B (de) | Verfahren zur Herstellung neuer N-Carbalkoxy- bzw. -aralkoxyalkyl-β-(3,4-dihydroxyphenyl)-β-hydroxyäthylamine und deren Salze | |
| AT274808B (de) | Verfahren zur Herstellung von Imidazolderivaten | |
| DE1122070C2 (de) | Verfahren zur Herstellung von diuretisch wirksamen Disulfamylanilinverbindungen | |
| AT226710B (de) | Verfahren zur Herstellung von neuen Dihydrochinoxalonen-(2) und von deren Salzen | |
| AT215417B (de) | Verfahren zur Herstellung neuer N-Carbalkoxy- bzw. -aralkoxyalkyl-β-(3,4-dihydroxyphenyl)-β-hydroxyäthylamine und deren Salze | |
| AT244344B (de) | Verfahren zur Herstellung von neuen Pyrimidinverbindungen | |
| AT200134B (de) | Verfahren zur Herstellung von a-Amino-b-oxycarbonsäureamiden | |
| DE945237C (de) | Verfahren zur Herstellung von Pyrrolinonen | |
| AT239255B (de) | Verfahren zur Herstellung von neuen basisch substituierten Alkylxanthinderivaten | |
| DE1695580C (de) | Quaternare Verbindungen des Benzil saure beta piperidino athylesters und ein Verfahren zu ihrer Herstellung | |
| AT270647B (de) | Verfahren zur Herstellung neuer substituierter Aminopyridine, von deren Salzen und optisch aktiven Isomeren | |
| DE1900948C (de) | Cis- und trans-2-Methyl-5-(3, 4, S-trimethoxybenzamidoJ-decahydroisochinolin | |
| AT284126B (de) | Verfahren zur Herstellung neuer substituierter Aminopyrimidine und deren Salze und optisch aktiven Isomere | |
| DE2360317C3 (de) | Zwischenprodukte für neue Phenyläthylaminderivate und Verfahren zu deren Herstellung | |
| AT210886B (de) | Verfahren zur Herstellung von neuen, basisch substituierten Diphenylcarbinolestern und deren Salzen | |
| AT203482B (de) | Verfahren zur Darstellung von neuen N-Alkyl-p-toluolsulfonylaminoessigsäuren | |
| AT233570B (de) | Verfahren zur Herstellung von neuen N-Phenylpiperazinderivaten |